Fig. 12From: Simultaneous inhibition of FAK and ROS1 synergistically repressed triple-negative breast cancer by upregulating p53 signallingSchematic representation of the mechanism of the synergistic effect of crizotinib in combination with IN10018 in TNBCBack to article page